MARKET RADAR
SENSEX     NIFTY      
Dishman Pharmaceuticals & Chemicals Homepage >> Stock Price >> Dishman Pharma >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages

Dishman Pharmaceuticals & Chemicals

  BSE: 532526  |  NSE: DISHMAN  |  ISIN: INE353G01020
    
Add to Portfolio : Buy Date Qty Price |
60.70 0.80 (1.34%)
BSE : Feb 10, 17:00
Open 61.90 Vol 354,948
High 63.60 52 Wk 120.40
Low 59.85 52 Wk 32.50
Prev. Close 59.90    
60.70 0.70 (1.17%)
NSE : Feb 10, 17:00
Open 61.50 Vol 967,329
High 63.80 52 Wk 120.00
Low 60.00 52 Wk 33.80
Prev. Close 60.00    
- Related links
Track Dishman Pharmaceuticals & Chemicals 24x7
Get price sensitive and timely news updates on your mobile for just Re 1 a day
Activate Now
  Bid Offer
Price 60.70 0.00
Quantity 1,897.00 0.00
  Bid Offer
Price 60.55 60.70
Quantity 300.00 836.00
Market Cap 489.83 | * EPS (TTM) 3.59 | * P/E 16.91 | * P/C 8.59
* Book Value 79.27 | * Price/Book 0.77 | Div(%) 60.00 | Div Yield(%) 1.98
Market Lot 1.00 | Face Value 2.00 | Industry P/E 11.00
* As per latest stand alone adjusted profit after extra-ordinary items.

Historic Prices of Dishman Pharma

on 1 week 1 month 3 month 1 year 2 year 3 year
1 YearCurrent% Gain/Loss
Open Price 111.0061.90
High Price 116.4063.60
Low Price 111.0059.85
Last Price 115.1560.70-47.29
Volume175893549481,918.01

Financials of Dishman Pharma

Income Statement (Sep '11) (Mar '11)
  Quarterly Annual
Net Sales 107.69 419.57
Other Income 0.00 0.00
PBDIT 13.96 165.31
Net Profit -3.59 40.13
Profit & Loss | Half Yearly Results | Quarterly Results
Balance Sheet
Total Share Capital 16.14
Net Worth 641.38
Total Debt 561.67
Net Block 486.78
Investments 187.14
Net Current Assets 225.51
Total Assets 1203.04
Balance Sheet | Finished Goods | Raw Materials

Mutual Funds Holding - Dishman Pharma

Scheme No. of Shares
This stock is not held by any Mutual Fund over the last 6 months.

Compare with Peers

What's your call on Dishman Pharma

Experience the thrills of
investing with no risk

Community on Dishman Pharma

News Events - Dishman Pharma

BSE / NSE Notices - Dishman Pharma

Expert Advice - Dishman Pharma

No Expert Advice in the last 7 days

Queries on Dishman Pharma

Groups: Pharmaceuticals

Company Last Price Market Cap
Sun Pharma 541.30 56,056.05
Cipla 349.00 28,021.96
Dr Reddys Labs 1,619.85 27,452.54
Lupin 458.80 20,487.26
Ranbaxy Labs 443.30 18,679.03
more...

Compare with peers

Simple Moving Averages - Dishman Pharma

Days BSE NSE
30 47.71 47.73
50 43.73 43.74
150 58.29 58.25
200 66.93 66.88

Company Facts - Dishman Pharma

Registered Address

Bhadr - Raj Chambers,
Swastik Cross Road,,Navrangpura
Ahmedabad
Gujarat
380009

Tel: 079-26443053 079-26445807
Fax: 079-26420198
Email: dishman@dishmangroup.com
Website: http://www.dishmangroup.com

Registrars

Link Intime India Pvt. Ltd. C-13, Pannalal Silk Mills Compound,
LBS Marg,
Bhandup (W)

Mumbai - 400078
Maharashtra

Tel: 022-25963838, 25946970
Fax: 022-25946969
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Dishman Pharma

Name Designation
Janmejay R Vyas Chairman and Managing director
Arpit J Vyas Whole Time Director
Sanjay S Majmudar Director
Name Designation
Deohooti J Vyas Whole Time Director
Yagneshkumar B Desai Director
Ashok C Gandhi Director
Type
S Dishman Pharma
SMS to 51818 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Block Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Should Sachin be dropped as part of the rotation policy?
Yes
No
 

Follow moneycontrol.com